JP2023513189A5 - - Google Patents
Info
- Publication number
- JP2023513189A5 JP2023513189A5 JP2022547888A JP2022547888A JP2023513189A5 JP 2023513189 A5 JP2023513189 A5 JP 2023513189A5 JP 2022547888 A JP2022547888 A JP 2022547888A JP 2022547888 A JP2022547888 A JP 2022547888A JP 2023513189 A5 JP2023513189 A5 JP 2023513189A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- vitamin
- item
- composition according
- poly
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062971771P | 2020-02-07 | 2020-02-07 | |
| US62/971,771 | 2020-02-07 | ||
| US202062989487P | 2020-03-13 | 2020-03-13 | |
| US62/989,487 | 2020-03-13 | ||
| US202063047147P | 2020-07-01 | 2020-07-01 | |
| US63/047,147 | 2020-07-01 | ||
| PCT/IB2021/050975 WO2021156832A1 (en) | 2020-02-07 | 2021-02-06 | Use of mirna-485 inhibitors for treating amyotrophic lateral sclerosis (als) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023513189A JP2023513189A (ja) | 2023-03-30 |
| JP2023513189A5 true JP2023513189A5 (https=) | 2024-02-14 |
Family
ID=77200814
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022547888A Pending JP2023513189A (ja) | 2020-02-07 | 2021-02-06 | 筋萎縮性側索硬化症（ａｌｓ）を治療するためのｍｉｒｎａ－４８５阻害剤の使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230131083A1 (https=) |
| EP (1) | EP4100068A4 (https=) |
| JP (1) | JP2023513189A (https=) |
| KR (1) | KR20220154105A (https=) |
| CN (1) | CN115461086A (https=) |
| AU (1) | AU2021215407A1 (https=) |
| CA (1) | CA3166603A1 (https=) |
| MX (1) | MX2022009451A (https=) |
| WO (1) | WO2021156832A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4720313A1 (en) * | 2023-05-26 | 2026-04-08 | Shanghai Vitalgen Biopharma Co., Ltd. | Recombinant aav vectors for treating proteinopathies in central nervous system |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9951330B2 (en) * | 2013-07-11 | 2018-04-24 | The Trustees Of Columbia University In The City Of New York | Micrornas that silence tau expression |
| WO2016030899A1 (en) * | 2014-08-28 | 2016-03-03 | Yeda Research And Development Co. Ltd. | Methods of treating amyotrophic lateral scleroses |
| DE102016103562A1 (de) * | 2015-09-17 | 2017-03-23 | Topos Nomos Ltd. | Pharmazeutische Wirkstoffe zur Verwendung in der Behandlung von Amyotropher Lateralsklerose (ALS) und Diagnoseverfahren |
| DK3378482T5 (da) * | 2015-11-19 | 2024-09-30 | Univ Nagoya City Public Univ Corp | Formulering til administration af antitumorlægemiddel |
| WO2018139759A1 (ko) * | 2017-01-26 | 2018-08-02 | 주식회사 바이오오케스트라 | 마이크로 rna를 이용한 알츠하이머병 진단방법 |
| WO2018139819A1 (ko) * | 2017-01-26 | 2018-08-02 | 주식회사 바이오오케스트라 | 마이크로 rna를 이용한 뇌 질환 예방 또는 치료 용도 |
| JPWO2019240223A1 (ja) * | 2018-06-13 | 2021-07-01 | 公益財団法人川崎市産業振興財団 | 数平均分子量が３ｋＤａ〜１０ｋＤａであるＰＥＧブロックとカチオン性ポリマーとのブロックコポリマーと、アンチセンスオリゴヌクレオチドとを含む、ポリイオンコンプレックスミセル |
| US10844380B1 (en) * | 2019-06-17 | 2020-11-24 | Biorchestra Co., Ltd. | Uses for prevention or treatment of brain diseases using microrna |
-
2021
- 2021-02-06 AU AU2021215407A patent/AU2021215407A1/en not_active Abandoned
- 2021-02-06 CN CN202180026758.0A patent/CN115461086A/zh active Pending
- 2021-02-06 CA CA3166603A patent/CA3166603A1/en active Pending
- 2021-02-06 WO PCT/IB2021/050975 patent/WO2021156832A1/en not_active Ceased
- 2021-02-06 JP JP2022547888A patent/JP2023513189A/ja active Pending
- 2021-02-06 EP EP21751058.5A patent/EP4100068A4/en not_active Withdrawn
- 2021-02-06 MX MX2022009451A patent/MX2022009451A/es unknown
- 2021-02-06 US US17/760,342 patent/US20230131083A1/en active Pending
- 2021-02-06 KR KR1020227030526A patent/KR20220154105A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Peng et al. | Polymeric carriers for nucleic acid delivery: current designs and future directions | |
| JP2022538868A5 (https=) | ||
| Qi et al. | PEG-conjugated PAMAM dendrimers mediate efficient intramuscular gene expression | |
| Kaur et al. | Modified mRNA as a therapeutic tool for the heart | |
| Tagalakis et al. | Receptor-targeted liposome-peptide nanocomplexes for siRNA delivery | |
| Lv et al. | Fluorination on polyethylenimine allows efficient 2D and 3D cell culture gene delivery | |
| US10113151B2 (en) | Composition of viral vectors in lecithin liposomes, preparation method and treatment methods | |
| Kumar Giri et al. | Nanoliposome is a promising carrier of protein and peptide biomolecule for the treatment of cancer | |
| JP2023532536A5 (https=) | ||
| JP2023513188A5 (https=) | ||
| Sarisozen et al. | Lipid-based siRNA delivery systems: challenges, promises and solutions along the long journey | |
| JP2023513190A5 (https=) | ||
| Lin et al. | Sterically polymer-based liposomal complexes with dual-shell structure for enhancing the siRNA delivery | |
| Reimondez-Troitiño et al. | Versatile protamine nanocapsules to restore miR-145 levels and interfere tumor growth in colorectal cancer cells | |
| JP2023513189A5 (https=) | ||
| Balakrishnan et al. | Biopolymers augment viral vectors based gene delivery: Balaji Balakrishnan and Ernest David | |
| Oryan et al. | Basic concepts, current evidence, and future potential for gene therapy in managing cutaneous wounds | |
| Wang et al. | mRNA therapy for myocardial infarction: A review of targets and delivery vehicles | |
| Ouyang et al. | A biomimic reconstituted high-density-lipoprotein-based drug and p53 gene co-delivery system for effective antiangiogenesis therapy of bladder cancer | |
| JP2024501437A5 (https=) | ||
| Pan et al. | In vitro gene transfection in human glioma cells using a novel and less cytotoxic artificial lipoprotein delivery system | |
| JPWO2011025036A1 (ja) | 粒子組成物及びこれを有する医薬組成物 | |
| US12582669B2 (en) | Composition controlling pharmacokinetics in the body | |
| JP2024503302A5 (https=) | ||
| EP4124348A1 (en) | Nanoparticles for cell delivery |